Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Council Takes Only Small Steps Towards Consensus On HTA Regulations

Executive Summary

EU member state have several concerns about the European Commission’s plans for improving cooperation on health technology assessments, making it difficult for the Council of the EU to reach a common position on the proposals.

You may also be interested in...



Loud And Clear: EMA Gets Message On Advancing Reg Science

The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.

European Commission HTA Proposals Should Mandate Comparative Trials, Says Germany

Pharmaceutical companies should be obliged to carry out comparative trials, according to analysis from Germany’s Institute For Quality and Efficiency in Healthcare, IQWiG.

EU-Wide Joint Clinical Assessments Edge Closer

Legislation that would introduce EU-wide joint clinical assessments has moved a step forward after the European Parliament adopted its version of the proposals.

Related Content

Topics

UsernamePublicRestriction

Register

PS125502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel